🇺🇸 Repository corticotrophin in United States

Repository corticotrophin (Repository corticotrophin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Repository corticotrophin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Repository corticotrophin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Repository corticotrophin in United States?

Arizona Kidney Disease and Hypertension Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.